Optima Health grows 7%, eyes further acquisitions

Proactive - Interviews for investors

Optima Health PLC chief executive Jonathan Thomas talked with Proactive's Stephen Gunnion about the company’s recent trading performance and strategic progress since its AIM listing in 2024. Optima Health reported revenues of around £105 million for the year to 31 March, with second-half growth of approximately 7% compared to the first half. Thomas highlighted that adjusted EBITDA was in line with market expectations, and net debt was maintained at £2.2 million. "We believe [this] positions us really well to continue with our strategy," he said. Since listing, the company has completed three strategic acquisitions and secured a major seven-year contract in partnership with Serco to support the UK armed forces — a move described by Thomas as a "real milestone win". Additionally, Optima launched its proprietary DART platform into the NHS, enhancing its digital health presence. The acquisition of Care first was also discussed, adding £3.7 million in revenues and expanding Optima’s mental health and wellbeing capabilities. Thomas confirmed the acquisition is expected to be EBITDA accretive within the first year. Looking ahead, the company will focus on integrating acquisitions, delivering new contracts, and pursuing further value-accretive opportunities. Full-year results are expected in July. Visit Proactive’s YouTube channel for more updates. Don’t forget to like the video, subscribe to the channel, and enable notifications for future content. #OptimaHealth #JonathanThomas #UKHealth #AIMListing #HealthcareStocks #EmployeeWellbeing #NHSContracts #UKDefence #Serco #DigitalHealth #Carefirst #OccupationalHealth #MergersAndAcquisitions #InvestingInHealth #TradingUpdate